Tuberculosis, drug resistance in Canada

Titel:	Tuberculosis, drug resistance in Canada : reported susceptibility results of the Canadian tuberculosis laboratory surveillance system / Health Canada, Population and Public Health Branch, Centre for Infectious Disease Prevention and Control, Tuberculosis Prevention and Control
Veröffentlicht:	Ottawa : Minister of Public Works and Government Services Canada, 2010-
Erscheinungsverlauf:	Nachgewiesen 2009(2010) -
Umfang:	Online-Ressource
Format:	Elektronische Zeitschrift
Sprache:	Englisch
Schlagworte:	Tuberkulose Arzneimittelresistenz Kanada Zeitschrift
Frühere/Spätere Titel:	Vorg. als Druckausg.: . Tuberculosis, drug resistance in Canada
Andere Ausgaben:	Parallele Sprachausgabe französisch: La tuberculose, la résistance aux antituberculeux au Canada. - Ottawa : Minister of Public Works and Government Services Canada, 2000-. - Online-Ressource
ISSN:	1498-5071

alg: 28809026
001A    $06050:25-01-12 
001B    $06050:19-04-24 $t19:36:16.000 
001D    $06050:10-10-15 
001U    $0utf8 
001X    $00 
002@    $0Obvc 
002C    $aText $btxt $2rdacontent 
002D    $aComputermedien $bc $2rdamedia 
002E    $aOnline-Ressource $bcr $2rdacarrier 
003@    $0288090268 
003O    $01368835443 $aOCoLC 
005A    $01498-5071 
006Z    $02648203-4 
007A    $02648203-4 $aZDB 
009Q    $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $xH 
009Q    $uhttps://ezb.ur.de/?2648203-4 $xF 
010@    $aeng 
011@    $a2010 $n2010- 
013D    $RPresse $RFortlaufendes Sammelwerk $#Periodicals $#Yearbooks $#Périodiques $#Annuaires $#Publicaciones periódicas $#journals $#Periodical $#Periodicals as Topic $#Zeitschrift $#Zeitschrift $#Periodikum $#Zeitschriften $74067488-5 $8Zeitschrift [Tsz] $9085189774 
016A    $aDg 
018@    $0a 
021A    $aTuberculosis, drug resistance in Canada $dreported susceptibility results of the Canadian tuberculosis laboratory surveillance system $hHealth Canada, Population and Public Health Branch, Centre for Infectious Disease Prevention and Control, Tuberculosis Prevention and Control 
031@    $aNachgewiesen 2009(2010) - 
031N    $6 $j2009 
033A    $pOttawa $nMinister of Public Works and Government Services Canada 
034D    $aOnline-Ressource 
037A    $aGesehen am 29.11.17 
039E    $aVorg. als Druckausg. $bf $8--Abvc--. Tuberculosis, drug resistance in Canada $9108433668 
039M    $aParallele Sprachausgabe $8--Obvc--. La @tuberculose, la résistance aux antituberculeux au Canada. - Ottawa : Minister of Public Works and Government Services Canada, 2000-. - Online-Ressource. - ISSN 1498-508X $9288090640 $nfranzösisch 
044K    $qZDB $RBakterielle Infektion $#Tuberculosis $#Tuberculose $#Tuberculosis $#tuberculosis $#Tuberculosis $#Tbc $#Tuberculosis $74130621-1 $8Tuberkulose [Ts1] $9085462535 
044K    $qZDB $RTherapieresistenz $#Drug resistance $#Résistance aux médicaments $#Resistencia a los medicamentos $#drug resistance $#Drug Resistance $#Chemoresistenz Arzneimittelresistenz $#Medikamentös therapierefraktäres Verhalten $#Pharmakoresistenz $74143180-7 $8Arzneimittelresistenz [Ts1] $9085560863 
044K    $qZDB $RProvinz Kanada $#Canada $#Dominion of Canada $#Puissance du Canada $74029456-0 $8Kanada [Tg1] $9085077887 
045T    $aPHARM $qDE-84 $2FID 
045T    $a15,3 
045U    $e310 $e610 

lok: 28809026 3

exp: 28809026 3 1 #EPN
201B/01 $027-04-24 $t05:14:12.512 
201U/01 $0utf8 
203@/01 $0637098366 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=UBFM $XF 

lok: 28809026 5

exp: 28809026 5 1 #EPN
201B/01 $027-04-24 $t05:14:12.520 
201U/01 $0utf8 
203@/01 $0637098374 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=FHF $XF 

lok: 28809026 8

exp: 28809026 8 1 #EPN
201B/01 $027-04-24 $t05:14:12.525 
201U/01 $0utf8 
203@/01 $0637098382 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=TUDA $XF 

lok: 28809026 10

exp: 28809026 10 1 #EPN
201B/01 $027-04-24 $t05:14:12.530 
201U/01 $0utf8 
203@/01 $0637098390 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=FHDA $XF 

lok: 28809026 11

exp: 28809026 11 1 #EPN
201B/01 $027-04-24 $t05:14:12.536 
201U/01 $0utf8 
203@/01 $0637098404 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=HLB $XF 

lok: 28809026 20

exp: 28809026 20 1 #EPN
201B/01 $027-04-24 $t05:14:12.539 
201U/01 $0utf8 
203@/01 $0637098420 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=FHGF $XF 

lok: 28809026 21

exp: 28809026 21 1 #EPN
201B/01 $027-04-24 $t05:14:12.544 
201U/01 $0utf8 
203@/01 $0637098439 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=FHFD $XF 

lok: 28809026 23

exp: 28809026 23 1 #EPN
201B/01 $027-04-24 $t05:14:12.549 
201U/01 $0utf8 
203@/01 $0637098447 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=UBKAS $XF 

lok: 28809026 24

exp: 28809026 24 1 #EPN
201B/01 $029-11-17 $t22:56:47.302 
201U/01 $0utf8 
203@/01 $0637098455 
208@/01 $a25-01-12 $bl 
209S/01 $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $XH 

lok: 28809026 25

exp: 28809026 25 1 #EPN
201B/01 $027-04-24 $t05:14:12.554 
201U/01 $0utf8 
203@/01 $0637098463 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=UBMZ $XF 

lok: 28809026 36

exp: 28809026 36 1 #EPN
201B/01 $027-04-24 $t05:14:12.569 
201C/01 $011-01-22 
201U/01 $0utf8 
203@/01 $01176537016 
208@/01 $a11-01-22 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=RGZM $XF 

lok: 28809026 49

exp: 28809026 49 1 #EPN
201B/01 $021-02-20 $t16:06:07.950 
201C/01 $021-02-20 
201U/01 $0utf8 
203@/01 $01083493221 
208@/01 $a21-02-20 $bl 
209S/01 $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $XH 

lok: 28809026 50

exp: 28809026 50 1 #EPN
201B/01 $029-11-17 $t22:56:47.306 
201U/01 $0utf8 
203@/01 $063709848X 
208@/01 $a25-01-12 $bl 
209S/01 $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $XH 

lok: 28809026 54

exp: 28809026 54 1 #EPN
201B/01 $002-12-19 $t22:43:06.907 
201C/01 $002-12-19 
201U/01 $0utf8 
203@/01 $01071500295 
208@/01 $a02-12-19 $bl 
209S/01 $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $XH 

lok: 28809026 58

exp: 28809026 58 1 #EPN
201B/01 $029-11-17 $t22:56:47.314 
201U/01 $0utf8 
203@/01 $0637098498 
208@/01 $a25-01-12 $bl 
209S/01 $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $XH 

lok: 28809026 74

exp: 28809026 74 1 #EPN
201B/01 $029-11-17 $t22:56:47.318 
201U/01 $0utf8 
203@/01 $0733940102 
208@/01 $a27-06-14 $bl 
209S/01 $S0 $uhttps://www.canada.ca/en/services/health/publications/diseases-conditions.html $XH 

lok: 28809026 107

exp: 28809026 107 1 #EPN
201B/01 $027-04-24 $t05:14:12.590 
201C/01 $002-12-19 
201U/01 $0utf8 
203@/01 $01071500309 
208@/01 $a02-12-19 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=MARTI $XF 

lok: 28809026 108

exp: 28809026 108 1 #EPN
201B/01 $027-04-24 $t05:14:12.620 
201C/01 $002-12-19 
201U/01 $0utf8 
203@/01 $01071500317 
208@/01 $a02-12-19 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=THB $XF 

lok: 28809026 204

exp: 28809026 204 1 #EPN
201B/01 $027-04-24 $t05:14:12.632 
201U/01 $0utf8 
203@/01 $0637098501 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=UBGIE $XF 

lok: 28809026 205

exp: 28809026 205 1 #EPN
201B/01 $027-04-24 $t05:14:12.637 
201U/01 $0utf8 
203@/01 $063709851X 
208@/01 $a25-01-12 $bl 
209S/01 $uhttps://ezb.ur.de/?2648203-4&bibid=UBMA $XF

LEADER	00000cas a2200000 c 4500
001	288090268
003	DE-603
005	20240419193616.0
007	cr\|\|\|\|\|\|\|\|\|\|\|\|
008	120125c20109999xx a\| p\|o 0 \|1eng c
016	7		\|2 DE-600 \|a 2648203-4
022			\|a 1498-5071
035			\|a (DE-599)ZDB2648203-4
035			\|a (OCoLC)1368835443
040			\|a DE-603 \|b ger \|c DE-603 \|d DE-603
041			\|a eng
084			\|a PHARM \|q DE-84 \|2 fid
084			\|a 15,3 \|2 ssgn
084			\|a 310 \|a 610 \|q DE-600 \|2 sdnb
245	0	0	\|a Tuberculosis, drug resistance in Canada \|b reported susceptibility results of the Canadian tuberculosis laboratory surveillance system \|c Health Canada, Population and Public Health Branch, Centre for Infectious Disease Prevention and Control, Tuberculosis Prevention and Control
264	3	1	\|a Ottawa \|b Minister of Public Works and Government Services Canada \|c 2010-
300			\|a Online-Ressource
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
362	0		\|a Nachgewiesen 2009(2010) -
363	0	1	\|8 1.1\x \|i 2009
500			\|a Gesehen am 29.11.17
650		7	\|a Tuberkulose \|0 (DE-588)4130621-1 \|0 (DE-603)085462535 \|2 gnd
650		7	\|a Arzneimittelresistenz \|0 (DE-588)4143180-7 \|0 (DE-603)085560863 \|2 gnd
651		7	\|a Kanada \|0 (DE-588)4029456-0 \|0 (DE-603)085077887 \|2 gnd
655		7	\|a Zeitschrift \|2 gnd-content \|0 (DE-588)4067488-5 \|0 (DE-603)085189774
775	0	8	\|i Parallele Sprachausgabe \|n französisch \|t La tuberculose, la résistance aux antituberculeux au Canada \|d Ottawa : Minister of Public Works and Government Services Canada, 2000- \|h Online-Ressource \|x 1498-508X \|w (DE-603)288090640 \|w (DE-600)2648205-8
780	0	0	\|i Vorg. als Druckausg. \|t Tuberculosis, drug resistance in Canada \|w (DE-603)108433668 \|w (DE-600)2094499-8
856			\|u https://www.canada.ca/en/services/health/publications/diseases-conditions.html \|x Verlag \|z kostenfrei
856			\|u https://ezb.ur.de/?2648203-4 \|x EZB
924	1		\|9 603 \|a (DE-603)637098366 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098374 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098382 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098390 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098404 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098420 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098439 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098447 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098455 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098463 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1176537016 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1083493221 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)63709848X \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1071500295 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098498 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)733940102 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1071500309 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)1071500317 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)637098501 \|b DE-603 \|c HES \|d d
924	1		\|9 603 \|a (DE-603)63709851X \|b DE-603 \|c HES \|d d

Tuberculosis, drug resistance in Canada

Links

Folgen Sie uns auf...